The Economist - USA (2021-12-18)

(Antfer) #1

44 Britain TheEconomistDecember18th 2021


nelasPangalos,AstraZeneca’sheadofre­
search,saysthefirmhopestotweakthe
recipetoavoidtheissue.
But,headds,thereis“littletono”evi­
denceofsuchadverseeventsoutsidethe
West:“Itmaybedrivenbygenetics,itmay
bedrivenbyoverreporting,whoknows?”
Indeed,AstraZeneca’svaccineisincreas­
ingly used elsewhere. Since production
surgedinSeptember,thecountrieswith
themostdosesareIndia(whichbanned
theexportofvaccinesmadethere),Brazil
andMexico.Covax,whichdistributesjabs
topoorcountries,isanotherbeneficiary.
Thevaccineis“startingtohitplaceslike
Malaysia,Nepal,Vietnam andThailand,
andthere’sa tonofpeopleinthesecoun­
tries”,notesSirJohn.
Thesurgeofdeliveriesinthesecond
halfof 2021 istheflipsideofAstraZeneca’s
strugglesinthefirst.Thefirmworkedwith
partnerstoestablish 25 manufacturingfa­
cilities in 15 countries. Its vaccines are
madeto a formula detailing just about
everythingthatcanbecontrolledina pro­
ductionfacility.Atfirstthefirm’sscientists
weretoooptimisticabouthowquicklyout­
putyieldswouldrise,butrealityhassince
caughtup. India’s SerumInstituteillus­
tratesthescaleofthegrowth.InJanuaryit
madefewerthan60mdoses;byNovember
it hadhit250m.
Onequestioniswhethertherewillbe
anotherinversionin2022,withdemand
failingto meetpotential output.In No­
vemberAstraZenecasaiditwouldstartto
makeaprofitondoses,andhad signed
dealsonthatbasisfor2022,withpriceson
a slidingscaledependingonthewealthof
the purchaser (the vaccine will remain
availableto poorcountries atcost, and
even in richer ones the firm will still
chargelessthanitsrivals).Itstwomain
sellingpointsarecheapnessandthelogis­
ticaladvantagethatdosesdonotneedtobe
kept very cold. AstraZeneca has estab­
lisheda newinternalunitforitsvaccines,
aswellasitspromisingantibodytherapy,
whichwasapprovedbyAmerica’sfdaon
December8th.Thiscanpreventcovidin

peoplewhodonotrespondtovaccines,in­
cludingtheimmune­suppressed.
Forecastingdemandhasbeenmadedif­
ficultbyOmicron,againstwhichtwodoses
ofAstraZenecaappeartoofferscantpro­
tectionfrominfectionandreducedprotec­
tionfromhospitalisation.Ifvaccinesneed
toberetooled,theprocesswilltakea bit
longerthanformrnajabs.Evenif demand
outsidetherichworldremainshigh,an­
alystsdonotexpectthevaccinetocontrib­
utemuchtoAstraZeneca’sbottomline,es­
pecially whencompared withthefirm’s
strengthsinoncologyandcardiovascular
disease.“WhenI thinkaboutthestock,I
don’teventhink aboutthevaccine asa
driver,”saysGarethPowellofPolarCapital,
aninvestorinthefirm.
PascalSoirot,AstraZeneca’s boss, has
alwaysinsistedthedecisiontomakethe
vaccinewasfundamentallyaltruisticrath­
erthancommercial,sayingthathischil­
drenwouldhavekilledhimifhedidnot
take the chance. Given the number of
stormshisfirmhashadtoweather,andthe
attentionthevaccinehasabsorbed,share­
holdersmaynotbeentirelygratefulforthe
gamble.Everyoneelseshouldbe.n

Shot-putters

Sources:Airfinity;WorldBank

2
Covid-19 vaccine deliveries

*ToDec8th †IncludesRomania

2.5

2.0

1.5

1.0

0.5

0
2020 2021

Sinovac

AstraZeneca

Pfizer

Sinopharm Moderna
Others

Global, cumulative, bn

Vaccine

Destination countries
By income group/organisation

Pfizer
0.9bndoses

COVAX

High†

Upper
middle

Lower
middle

Low

AstraZeneca
1.bndoses

Sep-Dec 202*

In need of a booster
Share prices, December 15th 2020=100

Source:RefinitivDatastream

1

350

300

250

200

150

100

50
2020 202

MSCI world
pharmaceuticals

Moderna

AstraZeneca Pfizer

Unionismandsocialattitudes

Saving Ulster


S


hortly before taking  command  in
May of the Ulster Unionist Party (uup), a
now­diminished  force  that  once  domin­
ated Northern Ireland, Doug Beattie gave a
memorable speech. “I am a straight man,”
he told the region’s assembly. “There is no
fix or cure for me; there is no therapy that
will  make  me  a  gay  man...Why  would  we
say that a gay man can be fixed or cured?” 
Those  words  from  a  decorated  veteran
of the war in Afghanistan helped convince
Northern  Ireland’s  legislators  to  call  for  a
ban on “gay conversion therapy” similar to
a  bill  under  consultation  in  England.  No
bill has yet been drafted—but the vote was
consequential,  all  the  same.  Its  most  im­
mediate effect was to trigger turmoil in the
Democratic  Unionist  Party  (dup),  which
over  the  past  two  decades  has  supplanted
the  uup as  the  main  voice  of  citizens,
mostly  Protestant,  who  favour  keeping
Northern Ireland in the United Kingdom. 
Arlene Foster, then the dup’s leader and
Northern  Ireland’s  first  minister,  ab­
stained;  few  party  members  followed  her
lead,  instead  voting  against  a  ban.  Within
days  her  political  career  was  over  and  the
dup was embroiled in leadership changes.
Only  in  hindsight  is  the  catalysing  role  of
the conversion­therapy vote clear. 
Faced  with  the  prospect  of  Sinn  Fein,
the  voice  of  militant  Irish  nationalism,
topping  next  year’s  elections  and  taking
the post of first minister, you might think
that  pro­Union  groups  would  make  com­
mon cause. Instead they remain scratchily
divided over matters of culture, identity—
and sexuality. A poll in November suggest­
ed  18%  would  plump  for  the  dup,  against
14% for the uupand 11% for the ultra­con­
servative Traditional Unionist Voice. (Sinn
Fein would get 24%.) 
Despite  being  taunted  as  a  “queer­lov­
er” at public meetings, Mr Beattie has stuck
to his guns. In October the uupreleased a
video with few words but telling images: a
girl playing Gaelic sports, people of differ­
ent races and a same­sex couple. He is also
liberal  on  abortion;  on  December  14th  he
helped vote down a dupbid to restrict late
terminations.  Such  shifting  attitudes  on
social  issues  have  prompted  some  politi­
cians  to  join  the  uup and  others  to  leave.
Harold McKee, a standard­bearer of union­
ism in the Mourne Mountains, quit on Oc­
tober  30th,  lamenting  that  gay  marriage
was counter to the “infallible word of God”.
Mr  Beattie  says  his  live­and­let­live

Parties that support ties with Britain
are gradually modernising
Free download pdf